<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Increased anticardiolipin antibody (ACLA) immunoglobulin (Ig) G titers are commonly found in children with arterial <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> (AIS) or <z:hpo ids='HP_0002326'>TIA</z:hpo> (AIS/<z:hpo ids='HP_0002326'>TIA</z:hpo>) </plain></SENT>
<SENT sid="1" pm="."><plain>The associated risk of <z:hpo ids='HP_0004831'>recurrent thromboembolism</z:hpo> is unknown </plain></SENT>
<SENT sid="2" pm="."><plain>OBJECTIVE: To determine the risk of <z:hpo ids='HP_0004831'>recurrent thromboembolism</z:hpo> associated with persistently increased ACLA titers of the IgG isotype in children with AIS/<z:hpo ids='HP_0002326'>TIA</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: The authors studied a cohort of children surviving first AIS/<z:hpo ids='HP_0002326'>TIA</z:hpo> tested by standardized ELISA for beta2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I-dependent ACLA of the IgG isotype </plain></SENT>
<SENT sid="4" pm="."><plain>Children with ACLA titers &gt;15 IgG <z:chebi fb="0" ids="16247">phospholipid</z:chebi> (GPL) units (per manufacturer's cutoff point) on more than two occasions &gt; or =6 weeks apart were classified as ACLA-positive (ACLA+) and compared with ACLA-negative (ACLA-) children with respect to recurrent <z:hpo ids='HP_0001907'>thromboembolic events</z:hpo> (AIS/<z:hpo ids='HP_0002326'>TIA</z:hpo>, sinovenous <z:mp ids='MP_0005048'>thrombosis</z:mp>, and extracerebral <z:hpo ids='HP_0001907'>thromboembolism</z:hpo>) </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The authors recruited 34 ACLA+ children and 151 ACLA- children </plain></SENT>
<SENT sid="6" pm="."><plain>Most ACLA+ children (30/34; 88%) had ACLA titers &lt; or =40 GPL units </plain></SENT>
<SENT sid="7" pm="."><plain>During the follow-up period (median duration, 2.8 years for ACLA+ children and 3.0 years for ACLA- children), AIS/<z:hpo ids='HP_0002326'>TIA</z:hpo> recurred in 26% of ACLA+ children and in 38% of ACLA- children; none developed sinovenous <z:mp ids='MP_0005048'>thrombosis</z:mp> or extracerebral <z:hpo ids='HP_0001907'>thromboembolism</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Based on survival analysis, this difference was nonsignificant (p = 0.54) </plain></SENT>
<SENT sid="9" pm="."><plain>Using binary partition evaluation, no titer criteria for ACLA positivity (range, 0 to 60 GPL units) predicted recurrent AIS/<z:hpo ids='HP_0002326'>TIA</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: In children surviving arterial <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo>/<z:hpo ids='HP_0002326'>TIA</z:hpo>, increased anticardiolipin antibody immunoglobulin G titers do not predict <z:hpo ids='HP_0004831'>recurrent thromboembolism</z:hpo> </plain></SENT>
</text></document>